MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Alzchem Group Stock

Alzchem Group AG

ACT0.DEXETRAMarkt
€162.80
+0.5% today

Company data

Sector
Basic Materials
Industry
Chemicals
Country
Germany
CEO
Andreas Niedermaier
Employees
1,765
Market cap
€1.6 B
IPO
09/09/2026

Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that…

Alzchem Group stock: price history

31/08/26-1.1 %16/10/26

1D

+0.5%

1W

-0.2%

1M

+1.9%

6M

–

YTD

–

1Y

–

2Y

–

5Y

–

10Y

–

Next earnings date

Next earnings date

29/10/2026 (in 12 days)

Volatility around earnings

~21% weaker price swings than usual

Ask the agents about Alzchem Group

Free float & liquidity

FREE FLOAT

–

FLOAT SHARES

5,397,783

AVG. DAILY VOLUME (30D)

17,725

Dividends

EX-DATEPAY DATEAMOUNTYIELD
06/05/202608/05/2026€2.101.3 %
09/05/202513/05/2025€1.801.1 %
08/05/202410/05/2024€1.200.7 %
12/05/202316/05/2023€1.050.7 %
06/05/202210/05/2022€1.000.6 %

Comparable stocks

Frequently asked questions about Alzchem Group stock

What does Alzchem Group do?

Alzchem Group AG is a company in the Basic Materials sector, Chemicals industry, headquartered in Germany.

The CEO is Andreas Niedermaier, the company employs around 1,765 people.

The IPO was on 09/09/2026; the stock trades on XETRA under the ticker ACT0.DE.

When does Alzchem Group report next?

The next earnings date is 29/10/2026.

Around past earnings, price swings were roughly -21% stronger than usual.

Does Alzchem Group pay a dividend?

Yes. The last dividend was €2.10 per share, ex-date 06/05/2026, paid on 08/05/2026.

Which stocks are comparable to Alzchem Group?

Comparable stocks include BASF, Dow, DuPont de Nemours, Sasol, Huntsman and Braskem.

How can I get Alzchem Group stock analyzed?

Clicking "Analyze stock" lets five strategies assess Alzchem Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.